Effects of Oral NMRA-335140 in people with Major Depressive Disorder
This study is completed in the United States, in France, in Bulgaria, .... It is testing Effects of Oral NMRA-335140 for depression.
In United States
Compare studies and check their requirements with the research team.
This study is completed in the United States, in France, in Bulgaria, .... It is testing Effects of Oral NMRA-335140 for depression.
In United StatesThis study is completed in the United States, in Canada, in Brazil, .... It is testing Effects of Oral NMRA-335140 for depression.
In United StatesThis study is completed in the United States, in Bulgaria, in Czechia, .... It is testing NBI-1065845 for depression.
In United StatesThis study is completed in the United States. It is testing Efficacy, Safety, and Tolerability of AZD8529 for schizophrenia.
In United StatesThis study was terminated in the United States, in France, in Canada, .... It focuses on Depression.
In United StatesThis study is completed in the United States. It is testing Safety and Efficacy of NRP104 for ADHD.
In United StatesThis study is completed in the United States. 5, 5, or 10 mg for Bipolarity.
In United StatesThis study is completed in the United States. It is testing Safety and Pharmacokinetics of CY6463 for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Brexpiprazole (OPC- 34712) for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen for schizophrenia.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is completed in the United States. It is testing topiramate for OCD.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.